Press release - 01/08/2012 With broccoli against infections The microbiologist and immunologist Prof. Dr. Andreas Diefenbach, Institute of Medical Microbiology and Hygiene, University of Freiburg Medical Centre, has been awarded a European Research Council "Starting Grant" for his project "NutrImmune". The ERC Starting Grant is one of Europe’s most prestigious grants for young investigators.https://www.gesundheitsindustrie-bw.de/en/article/press-release/with-broccoli-against-infections
Article - 29/05/2012 Exploring special antibiotics synthesis pathways Kirromycin, an antibiotic produced by soil bacteria, reveals unusual steps for biosynthesis that might also be of interest for biotechnological applications. Dr. Ewa Maria Musiol was the first to shed light on the functions of specific acyltransferases involved in the biosynthesis of the antibiotic. She also received the 2012 DECHEMA PhD Award for Natural Products Research for these achievements.https://www.gesundheitsindustrie-bw.de/en/article/news/exploring-special-antibiotics-synthesis-pathways
Article - 19/03/2012 Soil bacteria to produce new antibiotics An ever-growing number of genomes of soil bacteria of the genus Streptomyces are being sequenced. Using a method known as “genome mining”, researchers at the University of Tübingen are working on the identification of gene clusters that have the potential to be used in industrial biotechnology for the production of new antibiotics and other pharmaceutically active substances. To achieve this, the biosynthesis gene clusters are integrated into…https://www.gesundheitsindustrie-bw.de/en/article/news/soil-bacteria-to-produce-new-antibiotics
Article - 16/01/2012 Alexander Titz: molecular design to combat antibiotic-resistant bacteria Pseudomonas aeruginosa has become an important cause of infection, and is often picked up in hospitals, especially by patients with weakened immune systems. It can cause respiratory and urinary tract infections, as well as lead to infections on implants and wounds. P. aeruginosa lives in a gel-like matrix, a so-called biofilm that is highly resistant to antibiotics, making it very difficult to eradicate. Dr. Alexander Titz and his team at the…https://www.gesundheitsindustrie-bw.de/en/article/news/alexander-titz-molecular-design-to-combat-antibiotic-resistant-bacteria
Article - 19/12/2011 New research training group to investigate bacterial survival strategies The University of Tübingen is to establish a new DFG-funded research training group in which doctoral students from twelve research groups will investigate bacterial survival strategies. The results will contribute to the development of new antimicrobial drugs and also be put to good use in the fields of epidemiology and ecology.https://www.gesundheitsindustrie-bw.de/en/article/news/new-research-training-group-to-investigate-bacterial-survival-strategies
Article - 21/11/2011 Johannes Huebner's interest in intestinal bacteria and their sweet-sour capsule Some Enterococcus species are common commensal organisms in human intestines and other species are used in raw-milk cheese where they enhance flavour development. On the negative side enterococci are also a common cause of hospital-acquired infections. Prof. Dr. Johannes Huebner from the Freiburg University Medical Centre is hoping that the bacterias capsular polysaccharides might at some point in the future be used as a vaccine opening the door…https://www.gesundheitsindustrie-bw.de/en/article/news/johannes-huebner-s-interest-in-intestinal-bacteria-and-their-sweet-sour-capsule
Article - 20/11/2011 Can probiotic lactic acid bacteria protect the intestines against pathogens? Nutrition scientists from the Max Rubner-Institut MRI in Karlsruhe are investigating how human pathogens and probiotic bacterial strains interact with each other in the human gastrointestinal tract. Are probiotic bacteria in yoghurt or in pickled vegetables for example able to reduce the health risk posed by pathogenic bacteria?https://www.gesundheitsindustrie-bw.de/en/article/news/can-probiotic-lactic-acid-bacteria-protect-the-intestines-against-pathogens
Press release - 10/10/2011 Vetter’s state-of-the-art Chicago facility is fully operational Vetter, a leading contract development and manufacturing organization that specializes in aseptic filling, today announced that its first U.S. facility is now fully operational. Located at the Illinois Science + Technology Park in suburban Chicago, the 24,000-square-foot site includes microbiology and chemical analysis labs, material preparation and compounding functions, three cleanrooms for aseptic filling, and visual inspection. The first to…https://www.gesundheitsindustrie-bw.de/en/article/press-release/vetter-s-state-of-the-art-chicago-facility-is-fully-operational
Article - 22/08/2011 IHB – Textile research that leads to new applications Innovative medical textiles can offer clear advantages when it comes to improvements in delivering modern health care systems. The Institute for Hygiene and Biotechnology (IHB) at the Hohenstein Institute is currently involved in the development of new fibre-based materials for successful applications in the private and public health sectors. Both natural biopolymers and stem cells have the potential of becoming part of such medical products of…https://www.gesundheitsindustrie-bw.de/en/article/news/ihb-textile-research-that-leads-to-new-applications
Press release - 04/08/2011 Testing water quality - Test kit makes in situ testing easy Moisture and warmth create the ideal living conditions for a wide range of micro-organisms which can pose a risk to human health. Now, a new quick testing kit for bacteria means that the microbiological contamination of water or other surfaces can be measured directly in situ, with no need for expensive and time-consuming laboratory tests.https://www.gesundheitsindustrie-bw.de/en/article/press-release/testing-water-quality-test-kit-makes-in-situ-testing-easy
Article - 25/07/2011 Cell culturing as a taught subject: many more “Biberachs” are needed Cell culture technology is only taught at a handful of universities. However, this interdisciplinary subject is the core of the “Pharmaceutical Biotechnology” programme offered by the Biberach University of Applied Sciences. We talked about the subject with Professor Jürgen Hannemann, founding dean of the “Pharmaceutical Biotechnology” programme, and with Professor Friedemann Hesse, who runs the “cell culture technology” teaching programme.https://www.gesundheitsindustrie-bw.de/en/article/news/cell-culturing-as-a-taught-subject-many-more-biberachs-are-needed
Press release - 04/05/2011 Vetter’s Chicago Facility Now Accepting Projects Vetter, a leading provider of aseptic prefilled drug-delivery systems, announced that its Chicago facility is accepting client projects. Located at the Illinois Science + Technology Park in Skokie, Illinois, the site supports preclinical through phase II products. https://www.gesundheitsindustrie-bw.de/en/article/press-release/vetter-s-chicago-facility-now-accepting-projects
Article - 14/02/2011 A molecule that enables local virus defence Dr. Markus Mordstein has spent the last four years as a doctoral student at the University of Freiburg investigating the previously relatively unknown interferon lambda. He has been able to show that this molecule has similar protective functions to type I interferons and he has also found that it is far more selective in terms of the site where it exerts its effect.https://www.gesundheitsindustrie-bw.de/en/article/news/a-molecule-that-enables-local-virus-defence
Article - 17/01/2011 nadicom GmbH: novel strategies to prove microcrobes guilty Microscopic life is omnipresent and it also appears in places where it is not wanted. The Karlsruhe-based nadicom Gesellschaft für angewandte Mikrobiologie mbH offers a broad range of services to companies and environmental authorities to help them deal with and control the omnipresence of microorganisms.https://www.gesundheitsindustrie-bw.de/en/article/news/nadicom-gmbh-novel-strategies-to-prove-microcrobes-guilty
Article - 03/12/2010 Review: Science meets Business Day 2010 (part II) How can plant physiologists and seed developers work together to achieve an understanding of the processes happening in the germinating plant embryo in order to improve the seed quality of sugar beet? How can virologists find new ways to switch off the flu virus and develop a marketable vaccine in cooperation with industrial partners?https://www.gesundheitsindustrie-bw.de/en/article/news/review-science-meets-business-day-2010-part-ii
Article - 29/11/2010 Max Rubner Institute – focusing on consumer health The research and analyses carried out by the Max Rubner Institute are aimed at protecting consumer health. The institute investigates the contamination of meat and fish and also focuses on the health benefits of food additives and the future of functional food.https://www.gesundheitsindustrie-bw.de/en/article/news/max-rubner-institute-focusing-on-consumer-health
Article - 08/11/2010 Molecular biology assisted by information theory What do the Internet and mobile communication have in common with the division of yeast cells and viruses? Quite a lot, says Martin Bossert, professor at the Institute of Telecommunication Technology and Applied Information Theory in Ulm. The 55-year-old engineer coordinates an interdisciplinary priority programme of the German Research Foundation (DFG, SPP 1395 Information and Communication Theory in Molecular Biology) that applies information…https://www.gesundheitsindustrie-bw.de/en/article/news/molecular-biology-assisted-by-information-theory
Article - 17/10/2010 A high-tech strategy to become a reference laboratory The Konstanz-based Labor Dr. Brunner is the first medical laboratory in Germany to use a worldwide revolutionary instrument for liquid sample processing in bacteriological laboratories. The Walk-Away Specimen Processor (WASP) is a faster and more reliable processor that automatically identifies resistant pathogens such as MRSA or ESBL-type bacteria that have become part of the growing number of antibiotic-resistant pathogens that cause…https://www.gesundheitsindustrie-bw.de/en/article/news/a-high-tech-strategy-to-become-a-reference-laboratory
Article - 11/10/2010 Georg Sprenger - virtuoso of bacterial metabolism manipulation Microorganisms can be taught to do things that they are unable to do naturally. Bacterial metabolisms can be changed in order to make the bacteria produce new products and convert new substrates. In addition, existing bacterial conversion strategies can be optimised for biotechnological applications. Prof. Dr. Georg Sprenger is the head of the Institute of Microbiology at the University of Stuttgart and he is an expert in this field.https://www.gesundheitsindustrie-bw.de/en/article/news/georg-sprenger-virtuoso-of-bacterial-metabolism-manipulation
Press release - 17/09/2010 Receptor blockage improves lung function in cystic fibrosis Dr. Dominik Hartl, who was recently appointed professor at the University Children’s Hospital in Tübingen, particularly focuses on the cellular processes associated with airway inflammation in cystic fibrosis. His research results will be featured as the cover story in Nature Medicine in September 2010.https://www.gesundheitsindustrie-bw.de/en/article/press-release/receptor-blockage-improves-lung-function-in-cystic-fibrosis
Press release - 09/09/2010 Jiangnan University, Wuxi Jiangnan University JU is one of Chinas key universities of the 211 Project and functions under the Ministry of Education. The university host the National Engineering Laboratory of Fermentation Technology the Key Laboratory of Industrial Biotechnology the Engineering Research Center of Bioactive Product Processing Jiangsu Province and the Collection of Industrial Microbes Resources. https://www.gesundheitsindustrie-bw.de/en/article/press-release/jiangnan-university-wuxi
Article - 06/09/2010 Plasma technology in the fields of medicine and pharmacy The field of medicine often requires materials that need to be sterile at the same time as having low thermal stability. The Institute of Plasma Research at the University of Stuttgart has developed a dry-heat plasma sterilisation method that is a faster, more effective and less dangerous alternative to previously used methods.https://www.gesundheitsindustrie-bw.de/en/article/news/plasma-technology-in-the-fields-of-medicine-and-pharmacy
Article - 09/08/2010 Quick and early detection of rare diseases Lysosomal storage diseases LSD are a group of around 50 rare inherited metabolic disorders. Only 12 LSDs have been described biochemically and microbiologically. Prof. Dr. Michael Przybylski from the Steinbeis Transfer Centre for Biopolymer Analysis and Proteomics at the University of Constance now hopes to change this situation. In a project carried out in cooperation with the biotech company Genzyme CEE Konstanz and the University of Timisoara…https://www.gesundheitsindustrie-bw.de/en/article/news/quick-and-early-detection-of-rare-diseases
Press release - 02/08/2010 Training that offers a wide range of prospects Graduates from the private training college of the Deutsches Erwachsenen-Bildungswerk (German Adult Education Centre) in Fellbach received their certifi-cates last Friday from principal Claudia Volz. The newly qualified assistants in chemical and pharmaceutical engineering were joined by twelve biotechnology assistants (BioTA). The year's top BioTA-graduate, Juliane Maget, received a Euro 250 award from BioRegio STERN Management GmbH. https://www.gesundheitsindustrie-bw.de/en/article/press-release/training-that-offers-a-wide-range-of-prospects
Article - 01/08/2010 Manfred Kist – 25 years of fascination for a stomach bacterium Helicobacter pylori is a genus of bacteria that inhabits the human stomach. The bacteria can cause duodenal and gastric ulcers and are also linked to the development of gastric cancer. Prof. Dr. Manfred Kist from the Freiburg University Medical Centre has spent around 25 years of his scientific career on investigating H. pylori a bent rod-shaped bacterium.https://www.gesundheitsindustrie-bw.de/en/article/news/manfred-kist-25-years-of-fascination-for-a-stomach-bacterium